Behind the Scenes: Cetaphil Rolls Out New Super Bowl-inspired Campaign
For some the Super Bowl is all about the big game, for others it’s the half-time show and for others still, it’s the commercials. And Cetaphil will be launching a new campaign in advance of the Super Bowl that was inspired by Gen Z’s growing interest in skincare and football. Taylor Swift and her association with the National […]
Cutera Begins AviClear Roll Out in the U.K., Europe, and Australia
Cutera announced the international limited commercial release of AviClear, a 1726nm laser which targets and suppresses the production of sebum to treat acne at its source. The company announced the limited release at the International Master Course on Aging Science (IMCAS) conference in Paris, France. AviClear is now commercially available, on a limited basis, in the […]
Galderma Takes the ‘Face of Cetaphil’ to New York Fashion Week
Cetaphil’s New York Fashion Week activation enlists influencers and consumers from 14 different countries to be the ‘Face of Cetaphil’ as an extension of the brand’s ‘We Do Skin, You Do You’ campaign, Participants will have entered a global contest to win a trip to New York City, where they will act as on-the-ground correspondents alongside other […]
Oh, The Places Dermatology Will Go in 2024!
In 2023, dermatologists and their patients welcomed new drugs for acne, psoriasis, alopecia areata, and more, and 2024 promises to deliver real-world data on these medications along with even more therapeutic innovations across the spectrum of cutaneous diseases. The Dermatology Digest asked key thought leaders and editorial advisory board members to take out their crystal balls and […]
Johnson & Johnson’s Oral IL-23 Receptor Blocker Shows Promise in Moderate-to-severe Plaque PsO
JNJ-2113, Johnson & Johnson’s oral IL-23 receptor blocker, showed positive results in moderate-to-severe plaque psoriasis, according to the Phase 2b FRONTIER 1 study published in the New England Journal of Medicine. JNJ-2113 is the first and only investigational targeted oral peptide inhibitor designed to block the IL-23 receptor. IL-23 plays a critical role in pathogenic T-cell […]
La Roche-Posay Taps Tennis Pro Jannik Sinner as Anthelios Global Brand Advocate
Italian tennis pro Jannik Sinner is La Roche-Posay’s new global brand advocate. This long-term collaboration aims to address the lack of protection and education around UV rays. leveraging La Roche-Posay’s Anthelios sunscreen collection. Mr. Sinner, who plays tennis outdoors all year long, will help raise awareness about the importance of photoprotection.
Neutrogena Rolls Out Sustainable Hydro Boost Water Gel Refill Pods
Neutrogena is launching its Hydro Boost Water Gel Refillable Jar + Refill Pod Starter Kit. This is the company’s first refillable jar and pod. When the Starter Kit jar runs empty, consumers twist and remove the empty pod and replace with a refill pod, reducing plastic waste by 89% compared to the brand’s refillable jar. “We […]
FDA to Review Biofrontera’s sNDA for Ameluz Dosage Increase
The U.S. Food and Drug Administration (FDA) has issued a “no filing review issues identified” letter regarding Biofrontera’s sNDA (supplementary New Drug Application) which aims to increase the maximally approved dosage from one to three tubes of Ameluz per treatment. The FDA has completed its filing review and will begin its substantive review of Biofrontera’s communication with […]
Diagnosing Skin Disease in Images of Darker Skin: Can AI Help?
When diagnosing skin diseases based solely on images, doctors don’t perform as well when the patient has darker skin, according to a new study from MIT researchers. The study, which included more than 1,000 dermatologists and general practitioners, found that dermatologists accurately characterized about 38% of the images they saw, but only 34% of those that showed […]
Don’t Miss Out: ASA Announces 2024 Grant Opportunities for Dermatology Researchers
The American Skin Association (ASA) announced its 2024 grant opportunities for dermatologists treating skin cancer and other diseases. “ASA is proud to announce that the 2024 grant opportunities to support medical and educational initiatives total nearly $750,000, which is the largest offering to date,” says ASA Chairman Howard P. Milstein in a news release. “For […]